129 related articles for article (PubMed ID: 3081646)
41. Analysis of deficiencies in IFN-gamma-mediated priming for tumor cytotoxicity in peritoneal macrophages from A/J mice.
Hamilton TA; Somers SD; Becton DL; Celada A; Schreiber RD; Adams DO
J Immunol; 1986 Nov; 137(10):3367-71. PubMed ID: 3095430
[TBL] [Abstract][Full Text] [Related]
42. Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells.
Alberati-Giani D; Malherbe P; Ricciardi-Castagnoli P; Köhler C; Denis-Donini S; Cesura AM
J Immunol; 1997 Jul; 159(1):419-26. PubMed ID: 9200481
[TBL] [Abstract][Full Text] [Related]
43. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway.
Lambert LE; Paulnock DM
J Immunol; 1987 Oct; 139(8):2834-41. PubMed ID: 3116096
[TBL] [Abstract][Full Text] [Related]
44. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
45. Selective inhibition of 28S ribosomal RNA in macrophages activated by interferon-gamma or -beta.
Varesio L; Clayton M; Radzioch D; Bonvini E
J Immunol; 1987 Apr; 138(7):2332-7. PubMed ID: 3104461
[TBL] [Abstract][Full Text] [Related]
46. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
Jun CD; Yoon HJ; Kim HM; Chung HT
Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
[TBL] [Abstract][Full Text] [Related]
47. Mouse immune interferon enhances fibronectin production of elicited macrophages.
Cofano F; Comoglio PM; Landolfo S; Tarone G
J Immunol; 1984 Dec; 133(6):3102-6. PubMed ID: 6436373
[TBL] [Abstract][Full Text] [Related]
48. Alteration of macrophage cytotoxicity through endogenous interferon and tumor necrosis factor alpha induction by propanil.
Theus SA; Tabor DR; Gandy J; Barnett JB
Toxicol Appl Pharmacol; 1993 Jan; 118(1):46-52. PubMed ID: 7679225
[TBL] [Abstract][Full Text] [Related]
49. Protein changes associated with stages of activation of mouse macrophages for tumor cell killing.
MacKay RJ; Russell SW
J Immunol; 1986 Aug; 137(4):1392-8. PubMed ID: 3090148
[TBL] [Abstract][Full Text] [Related]
50. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
[TBL] [Abstract][Full Text] [Related]
51. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
52. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
[TBL] [Abstract][Full Text] [Related]
53. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
Davis CE; Belosevic M; Meltzer MS; Nacy CA
J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
[TBL] [Abstract][Full Text] [Related]
54. Augmentation by bacterial lipopolysaccharide of antitumor potency of murine recombinant interferon-gamma against Lewis lung adenocarcinoma.
Nagao S; Sato K; Ogawa H; Osada Y
Jpn J Cancer Res; 1986 Feb; 77(2):212-8. PubMed ID: 3082834
[TBL] [Abstract][Full Text] [Related]
55. Effect of serotonin (5-HT) and other monoamines on murine macrophages: modulation of interferon-gamma induced phagocytosis.
Sternberg EM; Wedner HJ; Leung MK; Parker CW
J Immunol; 1987 Jun; 138(12):4360-5. PubMed ID: 3108386
[TBL] [Abstract][Full Text] [Related]
56. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
Sato K; Tomioka H; Saito H
Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
[TBL] [Abstract][Full Text] [Related]
57. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
58. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.
Nash TW; Libby DM; Horwitz MA
J Immunol; 1988 Jun; 140(11):3978-81. PubMed ID: 3131422
[TBL] [Abstract][Full Text] [Related]
59. Encapsulation is not involved in the activities of recombinant gamma interferon associated with multilamellar phospholipid liposomes on murine bone marrow-derived macrophages.
Hume DA; Nayar R
Lymphokine Res; 1989; 8(4):415-25. PubMed ID: 2509821
[TBL] [Abstract][Full Text] [Related]
60. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones.
Koff WC; Dunegan MA
J Immunol; 1985 Jul; 135(1):350-4. PubMed ID: 2582037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
